Robbins Farley’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.98K | Hold |
71
| – | – | ﹤0.01% | 118 |
|
|
2025
Q1 | $9.08K | Sell |
71
-28,181
| -100% | -$3.6M | ﹤0.01% | 108 |
|
|
2024
Q4 | $3.74M | Buy |
28,252
+907
| +3% | +$120K | 1.78% | 29 |
|
|
2024
Q3 | $3.98M | Buy |
27,345
+116
| +0.4% | +$16.9K | 2.01% | 20 |
|
|
2024
Q2 | $3.74M | Buy |
27,229
+1,144
| +4% | +$157K | 1.99% | 19 |
|
|
2024
Q1 | $3.58M | Buy |
26,085
+988
| +4% | +$136K | 1.88% | 17 |
|
|
2023
Q4 | $3.41M | Buy |
25,097
+3,158
| +14% | +$429K | 2.04% | 17 |
|
|
2023
Q3 | $2.68M | Buy |
21,939
+2,209
| +11% | +$270K | 1.81% | 19 |
|
|
2023
Q2 | $2.5M | Sell |
19,730
-689
| -3% | -$87.5K | 1.73% | 24 |
|
|
2023
Q1 | $2.64M | Buy |
20,419
+452
| +2% | +$58.4K | 1.76% | 18 |
|
|
2022
Q4 | $2.62M | Buy |
19,967
+5,549
| +38% | +$729K | 2.03% | 20 |
|
|
2022
Q3 | $1.69M | Buy |
14,418
+6,518
| +83% | +$762K | 1.38% | 37 |
|
|
2022
Q2 | $929K | Buy |
7,900
+5,677
| +255% | +$668K | 0.97% | 35 |
|
|
2022
Q1 | $290K | Sell |
2,223
-144
| -6% | -$18.8K | 0.22% | 47 |
|
|
2021
Q4 | $361K | Buy |
2,367
+100
| +4% | +$15.3K | 0.27% | 42 |
|
|
2021
Q3 | $367K | Buy |
2,267
+65
| +3% | +$10.5K | 0.27% | 48 |
|
|
2021
Q2 | $360K | Buy |
2,202
+89
| +4% | +$14.6K | 0.41% | 31 |
|
|
2021
Q1 | $311K | Buy |
+2,113
| New | +$311K | 0.27% | 47 |
|